Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Genotype-Tissue Expression (GTEx) project reveals functional large-effect rare variants (RVs) now can be recognized across human tissues

NIBMG Recruitment – Online Application

Ultra-processed Foods (UPFs) can lead to aging

Genotype-Tissue Expression (GTEx) project reveals functional large-effect rare variants (RVs) now can be recognized across human tissues
  • BiotechToday
  • World

Genotype-Tissue Expression (GTEx) project reveals functional large-effect rare variants (RVs) now can be recognized across human tissues

bioxone September 17, 2020September 17, 2020

-Sristi Raj Rai, Amity University Kolkata

In the whirlpool of diseases that strike humans, how worthy will it be to pinpoint the origin behind by just using 4 English alphabets that conclude specie’s fate? Hidden in 98% non-coding regions occurring in the large size of 6.4 bn bp human genome, with minor allele frequency (MAF) <1% are some large-effect rare variants (RVs), linked with risk of complex diseases. Therefore, recognizing abundantly present RVs and their functionality, eventually connecting to its phenotypic consequences is a tough task. However, Ferraro et al. crafted a way out by analyzing RVs contributing to outlier patterns in total gene expression (eOutliers), allelic expression (aseOutliers), and alternative splicing (sOutliers) with 838 donor’s data of both whole-genome and transcriptome in the Genotype-Tissue Expression (GTEx-v8) project.

Multi-tissue RNA-sequencing data informed each signal generated points to a unique class of RVs. The group developed a probabilistic model – Watershed to improve standard genome annotations by integrating all 3 signals from an individual to predict the variant function. These prognostics were verified through experimentation and evaluated for association with diverse traits through computational analysis. The report suggests more than 50 RVs are linked to diverse molecular effects affecting the human transcriptome across 49 tissues. The designed model promises improved disease gene identification and delivery of precision genomics.

SOURCE – Ferraro, N., Strober, B., Einson, J., Abell, N., Aguet, F., Barbeira, A., Brandt, M., Bucan, M., Castel, S., Davis, J., Greenwald, E., Hess, G., Hilliard, A., Kember, R., Kotis, B., Park, Y., Peloso, G., Ramdas, S., Scott, A., Smail, C., Tsang, E., Zekavat, S., Ziosi, M., Aradhana, Ardlie, K., Assimes, T., Bassik, M., Brown, C., Correa, A., Hall, I., Im, H., Li, X., Natarajan, P., Lappalainen, T., Mohammadi, P., Montgomery, S. and Battle, A., 2020. Transcriptomic signatures across human tissues identify functional rare genetic variation. Science, 369(6509), p.eaaz5900.

LINK – https://science.sciencemag.org/content/369/6509/eaaz5900.full

Find similar articles on bioXone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged diseases gene expression gene identification genomics Genotype-Tissue Expression GTEx-v8 human genome rare variants RNA-sequencing RVs whole-genome sequencing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Ultra-processed Foods (UPFs) can lead to aging

bioxone September 17, 2020

-Akash Pramanik,  D.Y.Patil Medical College, Kolhapur Telomeres are the specific DNA-structure found at both the ends of the chromosome which protects it from degradation and inter-chromosomal fusion. But telomeres shorten with each DNA replication and gradually with time, it leads to chromosomal degradation and cell death. The rate of telomere shortening may indicate the pace […]

Related Post

  • BiotechToday
  • World

The machinery behind auxin-mediated veins formation and regeneration

bioxone November 2, 2020November 1, 2020

Sayak Banerjee, Amity University Kolkata The human body utilizes the veins to transport nutrients and oxygen throughout the whole body. Likewise, plants also have a similar kind of vascular system consisting of highly organized veins which transport nutrients throughout the body. Scientists found that the phytohormone auxin, which has its significance in plant growth and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

VV116 vs. Nirmatrelvir-Ritonavir Against COVID-19

DNA tales April 23, 2023April 23, 2023

Tholkappian R, NIT Durgapur Nirmatrelvir is an oral inhibitor of the SARS-CoV-2’s, 3-chymotrypsin–like cysteine protease, while VV116 is a deuterated remdesivir hydro-bromide with potent activity against SARS-CoV-2. Nirmatrelvir-ritonavir was used to treat COVID-19 of low to moderate severity. However, its production could not meet the global supply demands. VV116 is one such oral analog of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

World Bladder Cancer Awareness Month – May 2021

bioxone May 15, 2021May 15, 2021

Anuska Sen, Team BioXone “Have you ever heard about bladder cancer?” That’s the question this year’s theme of World Bladder Cancer Awareness Month asks us. It is believed that this one question if asked to people can make many of us “Bladder Cancer Aware”. The World Bladder Cancer Awareness Month is celebrated in May each […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy